Day: April 20, 2026

MMJ International Holdings Joins Federal Lawsuit on 4/20 to Stop CMS From Introducing Unvalidated Cannabinoid Products Into America’s 65+ Population

"MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20: "Botanical Therapies...

Flatiron Health Publishes First Peer-Reviewed Validation Framework for AI-Extracted Real-World Oncology Data in Journal of Clinical Oncology

Three-pillar framework sets methodological benchmark for data quality and transparency in oncology dataNEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the publication...

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California

VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company”...

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Superior potency demonstrated versus leading TROP2 ADCs across bladder, lung and breast tumor models Novel RNA spliceosome-targeting payload PH1 shows...

ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy

Inside Information The ALLIANCE phase 2 trial demonstrated proof-of-concept after only 6 months of maintenance treatment in a broad patient...

Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health’s Patented PEX010 Botanical Drug Candidate

Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of WashingtonSecond psilocybin...

Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

Significant Milestone in Defined North American Commercialization StrategyVancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Rise Nano Optics Ltd. (CSE:...

Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products

The Company's Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under...

error: Content is protected !!